Key result
Beta-2 and non-selective beta-blockers retain antifibrillatory effects in hypokalemic rats, unlike beta-1 blockade.
Why the study?
Does selective beta-1, selective beta-2, or non-selective beta-blockade prevent early ischaemia-induced arrhythmias in normokalaemic and hypokalaemic rats?
Does selective beta-1, selective beta-2, or non-selective beta-blockade prevent early ischaemia-induced arrhythmias in normokalaemic and hypokalaemic rats?
Beta-2 receptor blockade retains antiarrhythmic efficacy during ischemia in hypokalemic rats, likely by alleviating hypokalemia, suggesting a substantial role for beta-2 mediated hypokalemia in arrhythmogenesis.
Beta-2 selective blockade may merit exploration for ischemia-related arrhythmias in hypokalemia; leaves open translation to human efficacy and practice.
Hypokalaemia (HK) is a risk factor for development of clinical arrhythmias, and epinephrine (Epi), released after myocardial infarction, may itself induce HK. The effects of selective beta 1- and beta 2-blockade with metoprolol (M) and ICI 118551 (I), respectively, and non-selective blockade with propranolol (P) against early ischaemia-induced arrhythmias were therefore compared in normokalaemic (NK) and dietary-induced HK rats. Plasma Epi, norepinephrine (NE), and K+ levels were also measured. All three blockers [5-10 mg/kg intravenously (i.v.)] were antifibrillatory in NK rats, whereas I and P (2-10 mg/kg) additionally reduced the number of ventricular premature beats. Coronary artery ligation increased plasma Epi levels in both NK an HK rats, but plasma NE increased further in HK rats. HK was also associated with an increased arrhythmia severity and negation of the antifibrillatory action of M. In contrast, I and P retained antiarrhythmic and antifibrillatory effects in HK animals and increased survival. Both I and P increased plasma K+ levels in both NK and HK animals whereas M did not. We concluded that beta 2-receptor-mediated HK after coronary occlusion may play a substantial role in arrhythmogenesis. Protection afforded by beta 2-blocking agents may be due to alleviation of HK in HK rats or to induction of hyperkalaemia in NK rats.
No takes yet. Share an insight, caveat, or question.
Winslow et al. (1989) studied early ischaemia-induced arrhythmias. metoprolol, ICI 118551, and propranolol was evaluated on early ischaemia-induced arrhythmias and survival. Beta-2 and non-selective beta-blockers retained antiarrhythmic and antifibrillatory effects and increased survival in hypokalaemic rats, whereas beta-1 blockade lost its antifibrillatory action.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: